from FiercePharma
FiercePharma takes a look at the ten priciest medications, including a treatment for lipoprotein lipase deficiency (Glybera, $1.21 million per year), a treatment for urea cycle disorders (Ravicti, $793,632), a therapy used to treat Pompe disease (Lumizyme, $626,400), and more.
Disclaimer: The viewpoint expressed in this article is the opinion of the author and is not necessarily the viewpoint of the owners or employees at Healthcare Staffing Innovations, LLC.
0 likes